Gastroenterology

The Ready, Set, Food! co-founder discusses how research and federal advisory shapes parental understanding of immunotherapy and food allergy prevention.

Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.

Investigators conduct the first ever treat-to-target study looking at ustekinumab maintenance therapy for Crohn’s disease patients.

The new drug is an osmotic laxative for the treatment of chronic idiopathic constipation in adults.

Investigators identify several factors linked to early intestinal surgery for Crohn’s disease patients including smoking, BMI, and maximum bowel wall thickness.

A pediatric gastroenterologist shares insight into building a strong trust with both patients and their families.

RBX2660 from Rebiotix will be assessed in a randomized study involving 300 patients.

What does a strong physician-patient connection look like in 2020?

New research shows no significant difference in the proportion of patients with gastrointestinal bleeding following anticoagulant or antiplatelet monotherapy.

The Duquesne University School of Nursing assistant professor and assistant dean shares guidance on stoma complication in patients with ostomy.

A 28-day patient log of gastrointestinal symptoms, stool consistency, psychological distress, and extraintestinal pain ratings informs investigators on the significance of markers.

In a new study, investigators generate a global estimate for children with HCV infections in 249 countries and territories.

A new study finds women and patients with a recent history of hospitalization were more likely to be colonized with C. difficile.

In a new study, investigators link inflammatory bowel disease with a number of negative maternal and placental outcomes.

Avapritinib represents the first ever treatment for a rare mutation for patients with gastrointestinal stromal tumors.

A panel that includes patients, clinicians, and methodologists create a new set of recommendations for treating gastrointestinal bleeding prophylaxis.

Investigators look at persistent symptoms for GERD patients taking proton pump inhibitors.

The chatbot could provide information to patients about the procedure whenever and wherever they want.

A specific allele could help predict whether a patient will develop anti-drug antibodies to infliximab and adalimumab for patients with Crohn’s disease.

In a new study, investigators examine whether a low FODMAP diet could be beneficial for patients suffering from quiescent IBD.

The once-daily therapy has been previously approved for treatment of adults with difficult-to-treat rheumatoid arthritis or psoriatic arthritis.

In a comparison, investigators find that surgery is more successful in treating GERD patients who do not respond to protein pump inhibitors.

In the last decade, investigators have put an emphasis on better disease monitoring for digestive diseases. The result has been better patient outcomes.

A systematic review shows women are putting their offspring at risk of various chronic conditions, based on their improper diets.

In a new trial, investigators find glecaprevir and pibrentasvir is safe to treatment HCV patients who failed treatment with an NS5A inhibitor.